Israel-based Vaxil Bio Ltd. appointed David Goren CEO and board member.
Goren previously held senior positions at drugmakers Pfizer Inc. and AstraZeneca PLC.
Vaxil develops and sells immunotherapies for cancer and other diseases in Israel.
Vaxil appoints CEO
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Vaxil appoints CEO
- Author Ephraim Bie
- Theme Healthcare & Pharmaceuticals
- Author
- Ephraim Bie
- Theme
- Healthcare & Pharmaceuticals